Company Overview of Formula Pharmaceuticals, Inc.
Formula Pharmaceuticals, Inc. develops novel therapeutics that target cancer stem cells and various minimal residual diseases. It offers FPI-01, a multi-peptide immunotherapeutic product candidate in clinical development for the maintenance of first-remission in acute myeloid leukemia, mesothelioma, and other cancers. The company was founded in 2009 and is based in Berwyn, Pennsylvania.
1055 Westlakes Drive
Berwyn, PA 19312
Founded in 2009
Key Executives for Formula Pharmaceuticals, Inc.
Formula Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Essential Resources, Inc.||United States|
|ThoRx Laboratories, Inc.||United States|
|Redox Pharmaceutical Corporation||United States|
|14605 Incorporated||United States|
|LaneLabs USA, Inc.||United States|
Recent Private Companies Transactions
May 11, 2015
|Allogeneic, Non-Viral Chimeric Antigen Receptor Technology Platform|
To contact Formula Pharmaceuticals, Inc., please visit www.formulapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.